Vitamin D insufficiency prior to bariatric surgery: risk factors and a pilot treatment study
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Summary: Objective To assess vitamin D status and the influences of race, sun exposure and dietary vitamin D intake on vitamin D levels, and to evaluate two vitamin D repletion regimens in extremely obese patients awaiting bariatric surgery. Methods A cross‐sectional analysis of dietary vitamin D, sun exposure, PTH [intact (iPTH) and PTH(1‐84)] and 25‐hydroxyvitamin D (25OHD; differentiated 25OHD2 and 25OHD3) in 56 obese [body mass index (BMI) > 35 kg/m 2] men and women (age 20–64 years). In a pilot clinical trial, 27 subjects with 25OHD levels < 62 nmol/l were randomized to receive ergocalciferol or cholecalciferol for 8 weeks. Results Serum 25OHD was low (mean 45 ± 22 nmol/l) and was inversely associated with BMI (r = −0·36, P < 0·01). Each BMI increase of 1 kg/m 2 was associated with a 1·3 nmol/l decrease in 25OHD (P < 0·01). BMI, sun exposure, African American race and PTH predicted 40% of the variance in 25OHD (P < 0·0001). Serum 25OHD significantly increased at 4 and 8 weeks in both treatment groups (P < 0·001), whereas PTH(1‐84) declined significantly in subjects treated with cholecalciferol (P < 0·007) and tended to decrease following ergocalciferol (P < 0·09). Conclusions In severely obese individuals, those who are African American, have higher BMI and limited sunlight exposure are at greatest risk for vitamin D insufficiency. These demographic factors can help to identify at‐risk patients who require vitamin D repletion prior to bariatric surgery. Commonly prescribed doses of ergocalciferol and cholecalciferol are effective in raising 25OHD. Further investigation is needed to evaluate whether these regimens have differential effects on PTH, and to determine the optimal regimen for vitamin D repletion in the extremely obese patient.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Decreased bioavailability of vitamin D in obesity
Wortsman, J., Matsuoka, L. Y., Chen, T. C., Lu, Z., & Holick, M. F. (2000) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/72.3.690 · Cited by 3,204 · cited 8×
“Serum for PTH(1-84) was measured by Scantibodies Laboratory (Santee, CA, USA) using a manual 125I two-site immuno-radiometric assay (IRMA) [normal range 5–39 ng/l; interassay coefficient of variation (CV) 5.”
BackgroundMethodInfluentialEffect of Vitamin D on Falls: A Meta-analysis
Bischoff-Ferrari, H. A., Dawson-Hughes, B., Willett, W. C., Staehelin, H. B., Bazemore, M. G., Zee, R. Y., & Wong, J. B. (2004) · JAMA · doi:10.1001/jama.291.16.1999 · Cited by 1,324
Nesby-O’Dell, S., Scanlon, K. S., Cogswell, M. E., Gillespie, C., Hollis, B. W., Looker, A. C., Allen, C., Doughertly, C., Gunter, E. W., & Bowman, B. A. (2002) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/76.1.187 · Cited by 1,001 · cited 8×
“Serum for PTH(1-84) was measured by Scantibodies Laboratory (Santee, CA, USA) using a manual 125I two-site immuno-radiometric assay (IRMA) [normal range 5–39 ng/l; interassay coefficient of variation (CV) 5.”
BackgroundMethodInfluentialHyppönen, E., & Power, C. (2007) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/85.3.860 · Cited by 756 · cited 8×
“Serum for PTH(1-84) was measured by Scantibodies Laboratory (Santee, CA, USA) using a manual 125I two-site immuno-radiometric assay (IRMA) [normal range 5–39 ng/l; interassay coefficient of variation (CV) 5.”
BackgroundMethodInfluentialSlater, G. H., Ren, C. J., Siegel, N., Williams, T., Barr, D., Wolfe, B., Dolan, K., & Fielding, G. A. (2004) · Journal of Gastrointestinal Surgery · doi:10.1016/j.gassur.2003.09.020 · Cited by 489 · cited 8×
“Serum for PTH(1-84) was measured by Scantibodies Laboratory (Santee, CA, USA) using a manual 125I two-site immuno-radiometric assay (IRMA) [normal range 5–39 ng/l; interassay coefficient of variation (CV) 5.”
BackgroundMethodInfluentialEpidemiologic aspects of overweight and obesity in the United States☆
FLEGAL, K. (2005) · Physiology & Behavior · doi:10.1016/j.physbeh.2005.08.050 · Cited by 284 · cited 8×
“Serum for PTH(1-84) was measured by Scantibodies Laboratory (Santee, CA, USA) using a manual 125I two-site immuno-radiometric assay (IRMA) [normal range 5–39 ng/l; interassay coefficient of variation (CV) 5.”
BackgroundMethodInfluentialVitamin D status and bone histomorphometry in gross obesity
Compston, J. E., Vedi, S., Ledger, J. E., Webb, A., Gazet, J. C., & Pilkington, T. R. (1981) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/34.11.2359 · Cited by 249 · cited 8×
“Serum for PTH(1-84) was measured by Scantibodies Laboratory (Santee, CA, USA) using a manual 125I two-site immuno-radiometric assay (IRMA) [normal range 5–39 ng/l; interassay coefficient of variation (CV) 5.”
BackgroundMethodInfluential
Cited by
Heber, D., Greenway, F. L., Kaplan, L. M., Livingston, E., Salvador, J., & Still, C. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2128 · Cited by 521
Bariatric surgery and long-term nutritional issues
Lupoli, R., Lembo, E., Saldalamacchia, G., Avola, C. K., Angrisani, L., & Capaldo, B. (2017) · World Journal of Diabetes · doi:10.4239/wjd.v8.i11.464 · Cited by 431
Earthman, C. P., Beckman, L. M., Masodkar, K., & Sibley, S. D. (2012) · International Journal of Obesity · doi:10.1038/ijo.2011.119 · Cited by 430
Wamberg, L., Christiansen, T., Paulsen, S. K., Fisker, S., Rask, P., Rejnmark, L., Richelsen, B., & Pedersen, S. B. (2013) · International Journal of Obesity · doi:10.1038/ijo.2012.112 · Cited by 264
Review article: the nutritional and pharmacological consequences of obesity surgery
Stein, J., Stier, C., Raab, H., & Weiner, R. (2014) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12872 · Cited by 256
Metadata
- Authors
- Stein, E. M., Strain, G., Sinha, N., Ortiz, D., Pomp, A., Dakin, G., McMahon, D. J., Bockman, R., & Silverberg, S. J.
- Venue
- Clinical Endocrinology
- Publisher
- Wiley
- Published
- 2009-07-06
- Volume
- 71
- Issue
- 2
- Pages
- 176-183
- ISSN
- 0300-0664 (ISSN-L)
- 1365-2265
- OpenAlex
- W2121775518
- Cited by
- 111
- References
- 7
- FWCI
- 3.58
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.